Are you ready for the E2B(R2) to E2B(R3) update? This will be a significant and pivotal change. Do you still have questions or concerns? This webinar is a chance to learn more about the E2B(R3) change, and how to apply the update in your organization, from a top industry expert in the country.

The discussion will include:
  • Overview of E2B(R3) - What are the Changes and How This Impacts Your Organization
  • Implementation Guidance – Next Steps
  • Live Q & A Session 
About the Presenters:
Erin Northington

Vice President of Emerging Life Sciences Erin has two decades of experience in Clinical Applications, Business Relationship Management and Project Management. She also has a background in GCP compliance, vendor evaluation and management, systems validation and implementations, as well as process evaluation and improvement. She specializes in managing global enterprise-wide IT implementations of technology solutions.

Mark Ciresi
Mark Ciresi

Director of Drug safety systems, USDM Life Sciences Mark has 28 years of experience improving business productivity through the application of computer system solutions. Extensive knowledge of all aspects of computer systems and project life cycles in the field of health sciences.  Experience is balanced between business analysis, leadership, validation and development roles.

Want our experts to work on your project?

Take the first step towards creating more value with USDM today.

Connect Now

We use cookies to understand how you use our site and improve your experience. This includes personalizing content and advertising. Learn more.